修改瘤微环境可以通过等离子体基因疗法增强免疫力
Guilan Shi1, Jody Synowiec1, Julie Singh1
1Department of Medical Engineering, University of South Florida, Tampa, FL, 33612, USA.
Cancer gene therapy
|February 10, 2024
概括
质粒载体,而不仅仅是它们编码的分子,可以增强抗瘤免疫力. 在pUMVC3和pVax1载体的瘤内电穿孔上调MHC类I (MHC-I) 和PD-L1,减少小鼠模型中的瘤生长.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 癌症治疗 癌症治疗
背景情况:
- 通过电穿孔输送等离子体DNA的内输送显示了癌症治疗的前景.
- 以前的研究集中在编码的基因上,忽视了等离子体载体在免疫反应中的作用.
- 了解等离子体载体免疫调节对于优化基因治疗策略至关重要.
研究的目的:
- 为了研究等离子体载体pUMVC3和pVax1.1的免疫调节作用.
- 为了确定这些载体是否可以在瘤细胞上调节免疫标记物.
- 评估载体介导免疫调节对瘤生长 in vivo 的影响.
主要方法:
- 使用流细胞计分析瘤细胞系 (B16F10,4T1,KPC) 上的MHC I类 (MHC-I) 和PD-L1表达.
- 在已建立的瘤小鼠模型 (黑色素瘤,乳腺癌,胰腺癌) 中,对等离子体载体进行了门电解.
- 在接受治疗的动物模型中监测瘤生长和进展.
主要成果:
- pUMVC3和pVax1载体显著上调了B16F10,4T1和KPC瘤细胞上的MHC-I和PD-L1表达.
- 在B16F10,4T1和KPC小鼠模型中,pUMVC3缩瘤生长的内电穿孔.
- 这种pSTAT1信号通路似乎没有参与观察到的MHC-I和PD-L1.1的上调.
结论:
- 等离子体载体本身具有内在的特性,可以增强抗瘤免疫反应.
- 由等离子体载体对MHC-I和PD-L1的升调代表了癌症免疫治疗的新机制.
- 这些发现强调了在基因癌症治疗的设计中考虑等离子体载体的重要性.
更多相关视频
相关概念视频
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Gene Therapy
25.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.4K
Cancer Vaccines
367
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
367


